Genloxa
KRSCompany age:
Age:
14 y. 6 d.
Share capital:
Share capital:
20 000 PLN
Company Genloxa
KRS
0000395472
NIP
5871697047
REGON
221524108
| Address | 2, PL-84-100, RZUCEWO | |
| Voivodeship | Pomeranian | |
| Email address |
|
|
| Website | genloxa.pl | |
| Website | genloxa.pl |
Management
Wilandt Artur Maksymilian, prezes zarządu
Other management members ›
Beneficiaries of
3 beneficiaries
More ›
| Rating | |||
| Main industry | Research and experimental development on biotechnology | ||
| Account number |
PL22 2490 0005 0000 4600 4742 1681
PL44 2490 0005 0000 4530 9162 1028
PL51 2490 0005 0000 4600 4234 3209
|
| Patents | 2 active patents More › |
PKD codes:
72.11.Z - Research and experimental development on biotechnology
32.50.Z - Manufacture of medical and dental instruments and supplies
46.46.Z - Wholesale of pharmaceutical and medical goods
46.76.Z - Wholesale of other intermediate products
47.91.Z - Intermediation service activities for non-specialised retail sale
63.12.Z - Web portals
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods n.e.c.
86.90.E - Other human health activities not elsewhere classified
GENLOXA was established on 2011-09-08 and is currently located at 2, PL-84-100, RZUCEWO. The main activity of the company is scientific research and development. Other activities carried out by the company include data processing and hosting services, leasing of other machinery and equipment, physiotherapy activities, production of medical devices and products, retail sales outside the store network, various professional activities, various specialised wholesale, wholesale of household goods. As per the latest entry in the National Court Register, the current management board of the company comprises 3 individual(s). The most recent update in the National Court Register was recorded on 2025-07-14.